New Autism Study Safety Data to be Presented at the Translational Neuroscience Cell Symposium

Cord Blood Registry® (CBR®) announced today that Dr. Michael G. Chez principal investigator at Sutter Neuroscience Institute will present data from the first ever FDA-registered study on the safety of autologous umbilical cord blood (AUCB) stem cells in treating autism at the Translational Neuroscience: Bridging the Gap Between Basic Research Discoveries and Clinical Applications Cell Symposium on November 14 2014 in Arlington Virginia.Continue reading